Close Menu

In PLoS One this week, researchers at the Department of Energy's Joint Genome Institute and the University of Arizona report the completed sequence of Candidatus Sulcia meulleri, obtained from an uncultured single cell.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.